Enfusion earnings were $3.3M for the trailing 12 months ending Sep 30, 2024, with -50% growth year over year. The latest ENFN earnings report on Sep 30, 2024 announced Q3 2024 earnings of $1.4M, down 22.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ENFN reported annual earnings of $6.0M, with -178.7% growth. The next ENFN earnings date is Mar 10, 2025.
ENFN past earnings growth
How has ENFN's earnings growth performed historically?
On ENFN's earnings call on Invalid Date, Enfusion (NYSE: ENFN) reported Q3 2024 earnings per share (EPS) of $0.02, up 0% year over year. Total ENFN earnings for the quarter were $1.42 million. In the same quarter last year, Enfusion's earnings per share (EPS) was $0.02.
The next ENFN earnings date is Invalid Date. Add ENFN to your watchlist to be reminded of Enfusion's next earnings date.
What was ENFN's earnings growth in the past year?
As of Enfusion's earnings date in Invalid Date, Enfusion's earnings has grown -50% year over year. This is 208.15 percentage points lower than the US Software - Application industry earnings growth rate of 158.15%. ENFN earnings in the past year totalled $3.33 million.
Is Enfusion profitable or losing money?
As of the last Enfusion earnings report, Enfusion is currently profitable. Enfusion's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $3.33 million, a 43.61% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.